Prevention and treatment of major blood loss.
Szabo
Sebastian
S
Oikonomopoulos
Thomas
T
Hoffmeister
Hans Martin
HM
D000925:Anticoagulants / Q000009:adverse effects; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001026:Coronary Artery Bypass; D006470:Hemorrhage / Q000188:drug therapy / Q000517:prevention & control*; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D006493:Heparin